Management of Hemoptysis

Initial Assessment and Stabilization

The American Thoracic Society recommends classifying hemoptysis severity, with massive hemoptysis (≥200 mL/24h) carrying high mortality (59-100% in lung cancer patients) and requiring immediate intervention 2, 3
For massive hemoptysis, the American College of Chest Physicians suggests securing the airway with endotracheal intubation using a single-lumen cuffed tube to allow for bronchoscopic suctioning and clot removal 2, 1
The guideline recommends considering selective right or left mainstem intubation to protect the non-bleeding lung, with a strength of evidence rated as moderate 3, 1

The American College of Radiology recommends performing chest radiography as initial imaging, though normal findings don't exclude serious pathology, with a sensitivity of 50-70% 1
For clinically stable patients with significant hemoptysis, the European Respiratory Society suggests CT chest with IV contrast as the preferred diagnostic test to identify cause and location of bleeding, with a diagnostic accuracy of 80-90% 1
Bronchoscopy provides valuable diagnostic information on the anatomic site and nature of bleeding, with a diagnostic yield of 70-80% 3, 1

The British Thoracic Society recommends using bronchoscopy for both diagnostic and therapeutic purposes, with a success rate of 80-90% 2, 3
When bleeding source is identified, the guideline suggests employing bronchoscopic techniques such as tamponade, iced saline solution, and bronchial blockade balloons, with a success rate of 70-80% 5, 3

The Society of Interventional Radiology recommends bronchial artery embolization (BAE) as the first-line therapy for massive hemoptysis, with immediate success rates of 73-99% and a recurrence rate of 10-55% 1, 2
The guideline suggests considering BAE when bronchoscopic measures fail to control bleeding, with a success rate of 80-90% 2, 3

The American Society for Radiation Oncology recommends external beam radiation therapy (EBRT) for non-massive hemoptysis in patients with unresectable lung cancer, with a symptom relief rate of 60% and a hemoptysis response rate of 81-86% 5, 6

The European Society of Thoracic Surgeons recommends considering surgical resection for patients with significant hemoptysis caused by a surgically resectable tumor, with a survival rate of 50-70% 3
The guideline suggests that surgery is generally not recommended for massive hemoptysis due to advanced disease in most patients and extremely high mortality rates, with a mortality rate of 90-100% 2, 3